Recruiting Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus NCT07096193 Conditions Chronic Disease, Chronic Hepatitis Delta, Digestive System Diseases, +12 more Locations Investigative Site — Anaheim, California, United States University of Louisville, Clinical Trials Unit — Louisville, Kentucky, United States University of Maryland, Institute of Human Virology, Clinical Research Unit — Baltimore, Maryland, United States The New York-Presbyterian Hospital — New York, United States View all 22 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) NCT03852719 Conditions Chronic Disease, Chronic Hepatitis Delta, Digestive System Diseases, +12 more Locations New York University School of Medicine, an administrative unit of New York University, an education corporation — New York, United States Cornell University Well Madical College — New York, United States Universitätsklinikum Essen (AoR), Klinik für Gastroenterologie und Hepatologie — Essen, Germany Universitätsklinikum Frankfurt Medizinische Klinik 1 — Frankfurt am Main, Germany View all 19 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD) NCT03852433 Conditions Chronic Disease, Chronic Hepatitis Delta, Digestive System Diseases, +12 more Locations Hôpital Beaujon-Pavillon Abrami -Sce Hépatologie — Clichy, France Centre Hospitalier Universitaire Grenoble Alpes — Grenoble, France Hospital Croix Rousee — Lyon, France Hôpital Saint Joseph Hépato-Gastroentérologie — Marseille, France View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
